Dietary fat without body weight gain increases in vivo MCF-7 human breast cancer cell growth and decreases natural killer cell cytotoxicity

Molecular Carcinogenesis

Volumn 54, Issue 1, 2015, Pages 58-71

  Lamas, Bruno ^a   Nachat Kappes, Rachida ^a   Goncalves Mendes, Nicolas ^a   Mishellany, Florence ^b   Rossary, Adrien ^a   Vasson, Marie Paule ^a,c,d   Farges, Marie Chantal ^a  

^a INRA and University of Auvergne   (France)

^b EA 4677 ERTICA   (France)

^c Centre de Lutte Contre le Cancer Jean Perrin   (France)

^d UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

High calorie diet; Human breast carcinoma xenograft; NK cells

Indexed keywords

ADIPONECTIN; CASPASE 3; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; ESTROGEN RECEPTOR; FAT INTAKE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CANCER GROWTH; CITRIC ACID CYCLE; CONTROLLED STUDY; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FAT INTAKE; FEMALE; GENE CONTROL; GENE EXPRESSION; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LIPID METABOLISM; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; APOPTOSIS; BLOOD; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION REGULATION; MCF 7 CELL LINE; METABOLISM; NATURAL KILLER CELL; NUDE MOUSE; PATHOLOGY;

ANIMALS; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; CELL PROLIFERATION; DIETARY FATS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KILLER CELLS, NATURAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MCF-7 CELLS; MICE; MICE, NUDE; RECEPTORS, ESTROGEN;

EID: 84914697559     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22074     Document Type: Article

References (87)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
2. Bosetti C, Bertuccio P, Levi F, Chatenoud L, Negri E, La Vecchia C. The decline in breast cancer mortality in Europe: An update (to 2009). Breast 2012; 21:77-82.
3. Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103:714-736.
4. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
5. Chia KS, Reilly M, Tan CS, et al. Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: A comparative population-based study in Singapore and Sweden. Int J Cancer 2005; 113:302-306.
6. Knekt P, Albanes D, Seppanen R, et al. Dietary fat and risk of breast cancer. Am J Clin Nutr 1990; 52:903-908.
7. Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: Combined analysis of 12 case-control studies. J Natl Cancer Inst 1990; 82:561-569.
8. Kim EH, Willett WC, Colditz GA, et al. Dietary fat and risk of postmenopausal breast cancer in a 20-year follow-up. Am J Epidemiol 2006; 164:990-997.
9. Lof M, Sandin S, Lagiou P, et al. Dietary fat and breast cancer risk in the Swedish women's lifestyle and health cohort. Br J Cancer 2007; 97:1570-1576.
10. Kim EJ, Choi MR, Park H, et al. Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice. Breast Cancer Res 2011; 13:R78.
11. Gu JW, Young E, Patterson SG, et al. Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol Ther 2011; 11:910-917.
12. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity 2007; 15:798-808.
13. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 2007; 335:1134.
14. Stephenson GD, Rose DP. Breast cancer and obesity: An update. Nutr Cancer 2003; 45:1-16.
15. Rose DP, Connolly JM, Meschter CL. Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 1991; 83:1491-1495.
16. Marti A, Marcos A, Martinez JA. Obesity and immune function relationships. Obes Rev 2001; 2:131-140.
17. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB. Are natural killer cells protecting the metabolically healthy obese patient? Obesity 2009; 17:601-605.
18. O'Shea D, Cawood TJ, O'Farrelly C, Lynch L. Natural killer cells in obesity: Impaired function and increased susceptibility to the effects of cigarette smoke. PLoS ONE 2010; 5:e8660.
19. Nesaretnam K, Radhakrishnan A, Selvaduray KR, et al. Effect of palm oil carotene on breast cancer tumorigenicity in nude mice. Lipids 2002; 37:557-560.
20. Gruber TA, Skelton DC, Kohn DB. Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells. J Immunol 2002; 168:73-80.
21. Fearnside JF, Dumas ME, Rothwell AR, et al. Phylometabonomic patterns of adaptation to high fat diet feeding in inbred mice. PLoS ONE 2008; 3:e1668.
22. Olson LK, Tan Y, Zhao Y, Aupperlee MD, Haslam SZ. Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness. Int J Obes 2010; 34:1415-1426.
23. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-110.
24. Maillard S, Ameller T, Gauduchon J, et al. Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma. J Steroid Biochem Mol Biol 2005; 94:111-121.
25. Martin A, David V, Malaval L, Lafage-Proust MH, Vico L, Thomas T. Opposite effects of leptin on bone metabolism: A dose-dependent balance related to energy intake and insulin-like growth factor-I pathway. Endocrinology 2007; 148:3419-3425.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19:403-410.
27. Merlin E, Goncalves-Mendes N, Hannani D, et al. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. Transpl Immunol 2011; 24:100-106.
28. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004; 64:5245-5250.
29. Jungblut M, Oeltze K, Zehnter I, Hasselmann D, Bosio A. Preparation of single-cell suspensions from mouse spleen with the gentleMACS Dissociator. J Vis Exp 2008; 22:1029.
30. Allegra S, Deleine C, Michael-Jubely R, et al. Implementation of the EGFP-K562 flow cytometric NK test: Determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding. Cytometry A 2006; 69:992-998.
31. Marcelin G, Liu SM, Li X, Schwartz GJ, Chua S. Genetic control of ATGL-mediated lipolysis modulates adipose triglyceride stores in leptin-deficient mice. J Lipid Res 2012; 53:964-972.
32. Begriche K, Letteron P, Abbey-Toby A, et al. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice. Am J Physiol Endocrinol Metab 2008; 294:E939-E951.
33. Enerback S, Jacobsson A, Simpson EM, et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997; 387:90-94.
34. Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-49.
35. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol 2008; 9:503-510.
36. Dewan MZ, Terunuma H, Takada M, et al. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Breast Cancer Res Treat 2007; 104:267-275.
37. Bracke ME, Depypere HT, Boterberg T, et al. Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. J Natl Cancer Inst 1999; 91:354-359.
38. Caragine TA, Imai M, Frey AB, Tomlinson S. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity. Blood 2002; 100:3304-3310.
39. Screpanti V, Wallin RP, Grandien A, Ljunggren HG. Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol 2005; 42:495-499.
40. Cousins DJ, Staynov DZ, Lee TH. Regulation of interleukin-5 and granulocyte-macrophage colony-stimulating factor expression. Am J Respir Crit Care Med 1994; 150:S50-S53.
41. Nimer SD, Uchida H. Regulation of granulocyte-macrophage colony-stimulating factor and interleukin 3 expression. Stem Cells 1995; 13:324-335.
42. Zhang AL, Colmenero P, Purath U, et al. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 2007; 110:2484-2493.
43. Kim KY, Kang MA, Nam MJ. Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma. Cancer Lett 2001; 166:33-40.
44. van den Bosch G, Preijers F, Vreugdenhil A, Hendriks J, Maas F, De Witte T. Granulocyte-macrophage colony-stimulating factor (GM-CSF) counteracts the inhibiting effect of monocytes on natural killer (NK) cells. Clin Exp Immunol 1995; 101:515-520.
45. Smith AG, Sheridan PA, Harp JB, Beck MA. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007; 137:1236-1243.
46. Lautenbach A, Wrann CD, Jacobs R, Muller G, Brabant G, Nave H. Altered phenotype of NK cells from obese rats can be normalized by transfer into lean animals. Obesity 2009; 17:1848-1855.
47. Nave H, Mueller G, Siegmund B, et al. Resistance of Janus kinase-2 dependent leptin signaling in natural killer (NK) cells: A novel mechanism of NK cell dysfunction in diet-induced obesity. Endocrinology 2008; 149:3370-3378.
48. Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, et al. Involvement of adiponectin and leptin in breast cancer: Clinical and in vitro studies. Endocr Relat Cancer 2009; 16:1197-1210.
49. Jarde T, Perrier S, Vasson MP, Caldefie-Chezet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 2011; 47:33-43.
50. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004; 96:1152-1160.
51. Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. HDL-cholesterol and incidence of breast cancer in the ARIC cohort study. Ann Epidemiol 2008; 18:671-677.
52. Ray G, Husain SA. Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 2001; 34:71-76.
53. Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res 2000; 30:141-145.
54. Jozan S, Faye JC, Tournier JF, Tauber JP, David JF, Bayard F. Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions. Biochem Biophys Res Commun 1985; 133:105-112.
55. Rotheneder M, Kostner GM. Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: Differences between hormone-dependent and hormone-independent cell lines. Int J Cancer 1989; 43:875-879.
56. Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F. Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: Results from the prospective E3N cohort. Eur J Cancer Prev 2010; 19:120-125.
57. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 1999; 20:649-688.
58. Suchanek KM, May FJ, Robinson JA, et al. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231. Mol Carcinog 2002; 34:165-171.
59. Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, Gonzalez FJ. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 1998; 19:1989-1994.
60. Bocca C, Bozzo F, Martinasso G, Canuto RA, Miglietta A. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells. Br J Nutr 2008; 100:739-750.
61. Avis I, Hong SH, Martinez A, et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J 2001; 15:2007-2009.
62. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
63. Zhou S, Liu R, Yuan K, et al. Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis. Mass Spectrom Rev 2013; 32:267-311.
64. Buerkle A, Weber WA. Imaging of tumor glucose utilization with positron emission tomography. Cancer Metastasis Rev 2008; 27:545-554.
65. Chandra D, Singh KK. Genetic insights into OXPHOS defect and its role in cancer. Biochim Biophys Acta 2011; 1807:620-625.
66. Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ. Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 2005; 7:324-330.
67. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009; 324:1029-1033.
68. Brennan KR, Brown AM. Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 2004; 9:119-131.
69. Daugherty RL, Gottardi CJ. Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology 2007; 22:303-309.
70. Lim K, Han C, Dai Y, Shen M, Wu T. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. Mol Cancer Ther 2009; 8:3046-3055.
71. Calviello G, Resci F, Serini S, et al. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 2007; 28:1202-1209.
72. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408:239-247.
73. Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153:83-104.
74. Kattan Z, Minig V, Leroy P, Dauca M, Becuwe P. Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells. Breast Cancer Res Treat 2008; 108:203-215.
75. Yan W, Chen X. GPX2, a direct target of p63, inhibits oxidative stress-induced apoptosis in a p53-dependent manner. J Biol Chem 2006; 281:7856-7862.
76. Gouaze V, Andrieu-Abadie N, Cuvillier O, et al. Glutathione peroxidase-1 protects from CD95-induced apoptosis. J Biol Chem 2002; 277:42867-42874.
77. Park H, Kim M, Kwon GT, et al. A high-fat diet increases angiogenesis, solid tumor growth, and lung metastasis of CT26 colon cancer cells in obesity-resistant BALB/c mice. Mol Carcinog 2012; 51:869-880.
78. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444:337-342.
79. Huang YF, Shen MR, Hsu KF, Cheng YM, Chou CY. Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer. Br J Cancer 2008; 99:1096-1102.
80. Dearth RK, Kuiatse I, Wang YF, et al. A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis. BMC Cancer 2011; 11:377.
81. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat 2008; 109:241-250.
82. Acconcia F, Totta P, Ogawa S, et al. Survival versus apoptotic 17beta-estradiol effect: Role of ER alpha and ER beta activated non-genomic signaling. J Cell Physiol 2005; 203:193-201.
83. Roger P, Sahla ME, Makela S, Gustafsson JA, Baldet P, Rochefort H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 2001; 61:2537-2541.
84. Conneely OM, Jericevic BM, Lydon JP. Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 2003; 8:205-214.
85. Lin VC, Eng AS, Hen NE, Ng EH, Chowdhury SH. Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231. Clin Cancer Res 2001; 7:2880-2886.
86. van der Burg B, Kalkhoven E, Isbrucker L, de Laat SW. Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions. J Steroid Biochem Mol Biol 1992; 42:457-465.
87. Alkhalaf M, El-Mowafy A, Karam S. Growth inhibition of MCF-7 human breast cancer cells by progesterone is associated with cell differentiation and phosphorylation of Akt protein. Eur J Cancer Prev 2002; 11:481-488.